These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33148671)

  • 21. Genomic and transcriptomic characterisation of undifferentiated pleomorphic sarcoma of bone.
    Ali NM; Niada S; Brini AT; Morris MR; Kurusamy S; Alholle A; Huen D; Antonescu CR; Tirode F; Sumathi V; Latif F
    J Pathol; 2019 Feb; 247(2):166-176. PubMed ID: 30281149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene fusions in tumourigenesis with particular reference to ovarian cancer.
    Zhou Y; El-Bahrawy M
    J Med Genet; 2021 Dec; 58(12):789-795. PubMed ID: 34462289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential Unreliability of Uncommon ALK, ROS1, and RET Genomic Breakpoints in Predicting the Efficacy of Targeted Therapy in NSCLC.
    Li W; Guo L; Liu Y; Dong L; Yang L; Chen L; Liu K; Shao Y; Ying J
    J Thorac Oncol; 2021 Mar; 16(3):404-418. PubMed ID: 33248323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and Clinical Validation of a Large Fusion Gene Panel for Pediatric Cancers.
    Chang F; Lin F; Cao K; Surrey LF; Aplenc R; Bagatell R; Resnick AC; Santi M; Storm PB; Tasian SK; Waanders AJ; Hunger SP; Li MM
    J Mol Diagn; 2019 Sep; 21(5):873-883. PubMed ID: 31255796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic Validation of a Clinical Laboratory-Oriented Targeted RNA Sequencing System for Detecting Gene Fusions in Hematologic Malignancies.
    Lim HJ; Lee JH; Lee SY; Choi HW; Choi HJ; Kee SJ; Shin JH; Shin MG
    J Mol Diagn; 2021 Aug; 23(8):1015-1029. PubMed ID: 34082071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of recurrent, rare, and novel gene fusions in patients with acute leukemia using next-generation sequencing approaches.
    Kim B; Kim E; Lee ST; Cheong JW; Lyu CJ; Min YH; Choi JR
    Hematol Oncol; 2020 Feb; 38(1):82-88. PubMed ID: 31875988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating
    Rich TA; Reckamp KL; Chae YK; Doebele RC; Iams WT; Oh M; Raymond VM; Lanman RB; Riess JW; Stinchcombe TE; Subbiah V; Trevarthen DR; Fairclough S; Yen J; Gautschi O
    Clin Cancer Res; 2019 Oct; 25(19):5832-5842. PubMed ID: 31300450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines.
    Ha KC; Lalonde E; Li L; Cavallone L; Natrajan R; Lambros MB; Mitsopoulos C; Hakas J; Kozarewa I; Fenwick K; Lord CJ; Ashworth A; Vincent-Salomon A; Basik M; Reis-Filho JS; Majewski J; Foulkes WD
    BMC Med Genomics; 2011 Oct; 4():75. PubMed ID: 22032724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. InFusion: Advancing Discovery of Fusion Genes and Chimeric Transcripts from Deep RNA-Sequencing Data.
    Okonechnikov K; Imai-Matsushima A; Paul L; Seitz A; Meyer TF; Garcia-Alcalde F
    PLoS One; 2016; 11(12):e0167417. PubMed ID: 27907167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of RET fusions in a Chinese multicancer retrospective analysis by next-generation sequencing.
    Shi M; Wang W; Zhang J; Li B; Lv D; Wang D; Wang S; Cheng D; Ma T
    Cancer Sci; 2022 Jan; 113(1):308-318. PubMed ID: 34710947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In silico validation of RNA-Seq results can identify gene fusions with oncogenic potential in glioblastoma.
    Hernandez A; Muñoz-Mármol AM; Esteve-Codina A; Alameda F; Carrato C; Pineda E; Arpí-Lluciá O; Martinez-García M; Mallo M; Gut M; Del Barco S; Gallego O; Dabad M; Mesia C; Bellosillo B; Domenech M; Vidal N; Aldecoa I; de la Iglesia N; Balana C
    Sci Rep; 2022 Aug; 12(1):14439. PubMed ID: 36002559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic Yield From a Nationwide Implementation of Precision Medicine for all Children With Cancer.
    Wadensten E; Wessman S; Abel F; Diaz De Ståhl T; Tesi B; Orsmark Pietras C; Arvidsson L; Taylan F; Fransson S; Vogt H; Poluha A; Pradhananga S; Hellberg M; Lagerstedt-Robinson K; Raj Somarajan P; Samuelsson S; Orrsjö S; Maqbool K; Henning K; Strid T; Ek T; Fagman H; Olsson Bontell T; Martinsson T; Puls F; Kogner P; Wirta V; Pronk CJ; Wille J; Rosenquist R; Nistér M; Mertens F; Sabel M; Norén-Nyström U; Grillner P; Nordgren A; Ljungman G; Sandgren J; Gisselsson D;
    JCO Precis Oncol; 2023 Jun; 7():e2300039. PubMed ID: 37384868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diverse Oncogenic Fusions and Distinct Gene Expression Patterns Define the Genomic Landscape of Pediatric Papillary Thyroid Carcinoma.
    Stosic A; Fuligni F; Anderson ND; Davidson S; de Borja R; Acker M; Forte V; Campisi P; Propst EJ; Wolter NE; Chami R; Mete O; Malkin D; Shlien A; Wasserman JD
    Cancer Res; 2021 Nov; 81(22):5625-5637. PubMed ID: 34535459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types.
    Giacomini CP; Sun S; Varma S; Shain AH; Giacomini MM; Balagtas J; Sweeney RT; Lai E; Del Vecchio CA; Forster AD; Clarke N; Montgomery KD; Zhu S; Wong AJ; van de Rijn M; West RB; Pollack JR
    PLoS Genet; 2013 Apr; 9(4):e1003464. PubMed ID: 23637631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing data.
    Fernandez-Cuesta L; Sun R; Menon R; George J; Lorenz S; Meza-Zepeda LA; Peifer M; Plenker D; Heuckmann JM; Leenders F; Zander T; Dahmen I; Koker M; Schöttle J; Ullrich RT; Altmüller J; Becker C; Nürnberg P; Seidel H; Böhm D; Göke F; Ansén S; Russell PA; Wright GM; Wainer Z; Solomon B; Petersen I; Clement JH; Sänger J; Brustugun OT; Helland Å; Solberg S; Lund-Iversen M; Buettner R; Wolf J; Brambilla E; Vingron M; Perner S; Haas SA; Thomas RK
    Genome Biol; 2015 Jan; 16(1):7. PubMed ID: 25650807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variant analysis pipeline for accurate detection of genomic variants from transcriptome sequencing data.
    Adetunji MO; Lamont SJ; Abasht B; Schmidt CJ
    PLoS One; 2019; 14(9):e0216838. PubMed ID: 31545812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Multiplexed Amplicon Approach for Detecting Gene Fusions by Next-Generation Sequencing.
    Beadling C; Wald AI; Warrick A; Neff TL; Zhong S; Nikiforov YE; Corless CL; Nikiforova MN
    J Mol Diagn; 2016 Mar; 18(2):165-75. PubMed ID: 26747586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional linkage of gene fusions to cancer cell fitness assessed by pharmacological and CRISPR-Cas9 screening.
    Picco G; Chen ED; Alonso LG; Behan FM; Gonçalves E; Bignell G; Matchan A; Fu B; Banerjee R; Anderson E; Butler A; Benes CH; McDermott U; Dow D; Iorio F; Stronach E; Yang F; Yusa K; Saez-Rodriguez J; Garnett MJ
    Nat Commun; 2019 May; 10(1):2198. PubMed ID: 31097696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computational identification of micro-structural variations and their proteogenomic consequences in cancer.
    Lin YY; Gawronski A; Hach F; Li S; Numanagic I; Sarrafi I; Mishra S; McPherson A; Collins CC; Radovich M; Tang H; Sahinalp SC
    Bioinformatics; 2018 May; 34(10):1672-1681. PubMed ID: 29267878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene Fusion Detection and Characterization in Long-Read Cancer Transcriptome Sequencing Data with FusionSeeker.
    Chen Y; Wang Y; Chen W; Tan Z; Song Y; ; Chen H; Chong Z
    Cancer Res; 2023 Jan; 83(1):28-33. PubMed ID: 36318117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.